Zenith Drugs Limited IPO
Zenith Drugs' IPO offers 51,48,800 shares worth INR 40.68 crores. Funds will boost new unit machinery, block upgrades, working capital, and general needs.
Important Details
Date: Feb 19 to Feb 22, 2024 Listing Date: Feb 27, 2024 Price: INR 75-79 per share Lot Size: 1600 Shares Total Issue Size: INR 40.68 crores
Fundamental Analysis
Zenith Drugs IPO reveals strong growth with rising revenue, doubled equity, increased profitability, high RoNW, growing EPS, and improved asset management.
Peer Comparison
Zenith Drugs excels with a 29.88% RoNW and ₹4.29 EPS, outperforming Sudarshan Pharma and Sigachi Industries in profitability and operational efficiency.
Objective
Zenith Drugs aims to purchase machinery, upgrade the manufacturing block, and meet working capital needs. The balance funds support general corporate goals.
Risks And Challenges
Zenith Drugs faces global legal uncertainties, operational impacts, and API supplier challenges, risking business continuity and quality assurance.
Disclaimer:
&
*T&C Apply